s6y
Company name or ticker
Search
Adaptimmune Therapeutics PLC
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Filed
Monday, May 22, 2023
Accession number
0001104659-23-062910
Documents
425
425
On sec.gov
Filing index
All files
Complete submission text
SGML header